Toshimitsu Yamada Selected Research

2,3- dimethoxy- 6,6- dimethyl- 5,6- dihydrobenzo(7,8)indolizino (2,3-b)quinoxaline

7/2004

Effect of a novel interleukin-5 receptor antagonist, YM-90709 (2,3-dimethoxy-6,6-dimethyl-5,6-dihydrobenzo[7,8]indolizino[2,3-b]quinoxaline), on antigen-induced airway inflammation in BN rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshimitsu Yamada Research Topics

Disease

6	Inflammation (Inflammations) 04/2007 - 03/2002
5	Asthma (Bronchial Asthma) 01/2008 - 11/2002
2	Rhinitis 04/2006 - 07/2004
2	Atopic Dermatitis (Atopic Eczema) 07/2004 - 11/2002
1	Leukemia 01/2008
1	Respiratory Hypersensitivity 01/2008
1	Eosinophilia 04/2007
1	Nausea 07/2006
1	Vomiting 07/2006
1	Autoimmune Diseases (Autoimmune Disease) 05/2003
1	Hypersensitivity (Allergy) 05/2003
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2003
1	Overactive Urinary Bladder (Overactive Bladder) 08/2002
1	Bradycardia 08/2002
1	Arthritis (Polyarthritis) 03/2002
1	Experimental Arthritis 03/2002
1	Synovitis 03/2002
1	Rheumatoid Arthritis 03/2002
1	Disease Progression 03/2002
1	Body Weight (Weight, Body) 03/2002

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 01/2008 - 07/2004
3	4- methyl- 4'- (3,5- bis(trifluoromethyl)- 1H- pyrazol- 1- yl)- 1,2,3- thiadiazole- 5- carboxanilideIBA 01/2008 - 05/2003
2	Pharmaceutical PreparationsIBA 01/2008 - 08/2002
2	CytokinesIBA 01/2008 - 04/2007
2	Interleukin-5 (Interleukin 5)IBA 07/2004 - 11/2002
1	Immunoglobulin E (IgE)IBA 01/2008
1	LeukotrienesIBA 01/2008
1	Prednisolone (Predate)FDA LinkGeneric 01/2008
1	Calcium Release Activated Calcium ChannelsIBA 04/2007
1	Phosphodiesterase 4 InhibitorsIBA 07/2006
1	YM 976IBA 07/2006
1	N- (4,6- dimethylpyrimidin- 2- yl)- 4- (2- (4- methoxy- 3- methylphenyl)- 5- (4- methylpiperazin- 1- yl)- 4,5,6,7- tetrahydro- 1H- indol- 1- yl)benzenesulfonamide difumarateIBA 07/2006
1	CCR3 ReceptorsIBA 04/2006
1	CC ChemokinesIBA 04/2006
1	LigandsIBA 04/2006
1	Chemokine CCL24IBA 04/2006
1	Monocyte Chemoattractant ProteinsIBA 04/2006
1	Chemokine CCL26IBA 04/2006
1	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 07/2004
1	QuinoxalinesIBA 07/2004
1	2,3- dimethoxy- 6,6- dimethyl- 5,6- dihydrobenzo(7,8)indolizino (2,3-b)quinoxalineIBA 07/2004
1	Immunologic Factors (Immunomodulators)IBA 05/2003
1	pyrazoleIBA 05/2003
1	Solifenacin Succinate FDA Link 08/2002
1	oxybutynin (Tavor)FDA LinkGeneric 08/2002
1	1,2,3,4-tetrahydroisoquinolineIBA 08/2002
1	Muscarinic AntagonistsIBA 08/2002
1	Monoclonal AntibodiesIBA 03/2002
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 03/2002
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 08/2002